Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Harry Liao"'
Autor:
Fen Yang, Huali Wu, Yunhai Bo, Ye Lu, Hong Pan, Su Li, Qin Lu, Simin Xie, Harry Liao, Bing Wang
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Background: TQ-B3101 is a novel kinase inhibitor currently in development for the treatment of advanced malignant solid tumor and relapsed or refractory ALK-positive anaplastic large cell lymphoma.Methods: A population pharmacokinetic model was devel
Externí odkaz:
https://doaj.org/article/4e32a41f34df4898ab039f028db771d1
Autor:
Fen Yang, Huali Wu, Yunhai Bo, Ye Lu, Hong Pan, Su Li, Qin Lu, Simin Xie, Harry Liao, Bing Wang
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2022)
Frontiers in Pharmacology, Vol 12 (2022)
Background: TQ-B3101 is a novel kinase inhibitor currently in development for the treatment of advanced malignant solid tumor and relapsed or refractory ALK-positive anaplastic large cell lymphoma.Methods: A population pharmacokinetic model was devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2941966a667a37d91387b0a41b9a50a
https://pubmed.ncbi.nlm.nih.gov/35115931
https://pubmed.ncbi.nlm.nih.gov/35115931